Hepatitis C therapeutics: current status and emerging strategies (Q34988230)

5 August 2017

1 reference

title

Hepatitis C therapeutics: current status and emerging strategies (English)

1 reference

5 August 2017

1 reference

4

Nahum Sonenberg

1 reference

5 August 2017

Seng-Lai Tan

1

1 reference

PubMed ID

12415247

5 August 2017

Arnim Pause

series ordinal

2

1 reference

PubMed ID

12415247

5 August 2017

Yuguang Shi

series ordinal

3

1 reference

5 August 2017

1 November 2002

1 reference

Nature Reviews Drug Discovery

5 August 2017

1 reference

5 August 2017

1

1 reference

5 August 2017

11

1 reference

5 August 2017

867-881

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd937

5 August 2017

0 references

cites work

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

Hepatitis C: the clinical spectrum of disease

31 March 2020

1 reference

Hepatitis C: an epidemiological review

31 March 2020

1 reference

Analogy of human immunodeficiency virus to hepatitis C virus: the human immunodeficiency model

31 March 2020

1 reference

Interaction between the hepatitis C virus and the immune system

31 March 2020

1 reference

New therapeutic strategies for hepatitis C.

31 March 2020

1 reference

Novel approaches to the treatment of hepatitis C virus infection

31 March 2020

1 reference

New therapies for the treatment of chronic hepatitis C.

31 March 2020

1 reference

Advances in hepatitis C: what is coming in the next 5 years?

31 March 2020

1 reference

Novel cell culture systems for the hepatitis C virus

31 March 2020

1 reference

Hepatitis C virus replication in mice with chimeric human livers

31 March 2020

1 reference

The hepatitis C virus (HCV)-Trimera mouse: a model for evaluation of agents against HCV.

31 March 2020

1 reference

Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy

31 March 2020

1 reference

Recent advances in the molecular biology of hepatitis C virus

31 March 2020

1 reference

Sequences in the 5' nontranslated region of hepatitis C virus required for RNA replication.

31 March 2020

1 reference

Genetic Analysis of Sequences in the 3' Nontranslated Region of Hepatitis C Virus That Are Important for RNA Replication

31 March 2020

1 reference

Subcellular Localization and Topology of the p7 Polypeptide of Hepatitis C Virus

31 March 2020

1 reference

Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame

31 March 2020

1 reference

Synthesis of a novel hepatitis C virus protein by ribosomal frameshift

31 March 2020

1 reference

Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity

31 March 2020

1 reference

Replication of hepatitis C virus

31 March 2020

1 reference

Binding of hepatitis C virus to CD81

31 March 2020

1 reference

Low density lipoprotein receptor as a candidate receptor for hepatitis C virus

31 March 2020

1 reference

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

31 March 2020

1 reference

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

31 March 2020

1 reference

Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes

31 March 2020

1 reference

The interferon sensitivity determining region: all hepatitis C virus isolates are not the same

31 March 2020

1 reference

How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A.

31 March 2020

1 reference

The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy

31 March 2020

1 reference

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

31 March 2020

1 reference

Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.

31 March 2020

1 reference

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

31 March 2020

1 reference

Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin

31 March 2020

1 reference

Effects of combination therapy with interferon and ofloxacin on chronic type C hepatitis: a pilot study

31 March 2020

1 reference

Pilot study of ofloxacin and interferon-alpha combination therapy for chronic hepatitis C without sustained response to initial interferon administration

31 March 2020

1 reference

Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C.

31 March 2020

1 reference

Development of pegylated interferons for the treatment of chronic hepatitis C.

31 March 2020

1 reference

Peginterferon alfa-2a in patients with chronic hepatitis C.

31 March 2020

1 reference

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

31 March 2020

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

31 March 2020

1 reference

Dynamics of hepatitis C virus monitored by real-time quantitative polymerase chain reaction during first 2 weeks of IFN-beta treatment are predictive of long-term therapeutic response

31 March 2020

1 reference

Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha. Multicenter Interferon Beta Italian Group Investigators

31 March 2020

1 reference

Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C

31 March 2020

1 reference

Consensus interferon for chronic hepatitis C patients with genotype 1 who failed to respond to, or relapsed after, interferon alpha-2b and ribavirin in combination: an Italian pilot study

31 March 2020

1 reference

Evolution of a cytokine using DNA family shuffling

31 March 2020

1 reference

Hepatitis C and HIV co-infection: a review

31 March 2020

1 reference

Surprisingly small effect of antiviral treatment in patients with hepatitis C.

31 March 2020

1 reference

Biochemical and immunologic properties of the nonstructural proteins of the hepatitis C virus: implications for development of antiviral agents and vaccines.

31 March 2020

1 reference

Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides. Implications for control of viral processing

31 March 2020

1 reference

In vitro characterization of a purified NS2/3 protease variant of hepatitis C virus

31 March 2020

1 reference

A second hepatitis C virus-encoded proteinase

31 March 2020

1 reference

A collaborative screening program for the discovery of inhibitors of HCV NS2/3 cis-cleaving protease activity

31 March 2020

1 reference

Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo

31 March 2020

1 reference

Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase

31 March 2020

1 reference

Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus

31 March 2020

1 reference

Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease

31 March 2020

1 reference

Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease

31 March 2020

1 reference

Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA.

31 March 2020

1 reference

Structure of the hepatitis C virus RNA helicase domain

31 March 2020

1 reference

Crystallization and preliminary X-ray crystallographic analysis of the helicase domain of hepatitis C virus NS3 protein

31 March 2020

1 reference

The helicase from hepatitis C virus is active as an oligomer

31 March 2020

1 reference

The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding

31 March 2020

1 reference

Internal cleavage of hepatitis C virus NS3 protein is dependent on the activity of NS34A protease

31 March 2020

1 reference

Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA

31 March 2020

1 reference

RNA-dependent RNA polymerase encoded by hepatitis C virus: biomedical applications

31 March 2020

1 reference

Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus

31 March 2020

1 reference

Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site

31 March 2020

1 reference

Oligomeric interaction of hepatitis C virus NS5B is critical for catalytic activity of RNA-dependent RNA polymerase

31 March 2020

1 reference

Mutations in NS5B polymerase of hepatitis C virus: impacts on in vitro enzymatic activity and viral RNA replication in the subgenomic replicon cell culture

31 March 2020

1 reference

Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase

31 March 2020

1 reference

Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase

31 March 2020

1 reference

Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics

31 March 2020

1 reference

Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes

31 March 2020

1 reference

Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides

31 March 2020

1 reference

Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment

31 March 2020

1 reference

Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines

31 March 2020

1 reference

Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions

31 March 2020

1 reference

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

31 March 2020

1 reference

Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity

31 March 2020

1 reference

Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge

31 March 2020

1 reference

Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection

31 March 2020

1 reference

Studies of hepatitis C virus in chimpanzees and their importance for vaccine development.

31 March 2020

1 reference

Vaccine development for hepatitis C.

31 March 2020

1 reference

Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon

31 March 2020

1 reference

Targeting glycosylation as a therapeutic approach

31 March 2020

1 reference

Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking.

31 March 2020

1 reference

Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications

31 March 2020

1 reference

Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents

31 March 2020

1 reference

Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus

31 March 2020

1 reference

Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions

31 March 2020

1 reference

Antiviral effects of an iminosugar derivative on flavivirus infections

31 March 2020

1 reference

Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs

31 March 2020

1 reference

Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons

31 March 2020

1 reference

Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase

31 March 2020

1 reference

An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A

31 March 2020

1 reference

Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines

31 March 2020

1 reference

E2-p7 region of the bovine viral diarrhea virus polyprotein: processing and functional studies

31 March 2020

1 reference

31 March 2020

1 reference

Ancient pathways programmed by small RNAs.

31 March 2020

1 reference

siRNA-directed inhibition of HIV-1 infection

31 March 2020

1 reference

Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells

31 March 2020

1 reference

Modulation of HIV-1 replication by RNA interference

31 March 2020

1 reference

Short interfering RNA confers intracellular antiviral immunity in human cells

31 March 2020

1 reference

RNA interference in adult mice.

31 March 2020

1 reference

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders

31 March 2020

1 reference

A new route to apoptosis in hepatitis C virus infection

31 March 2020

1 reference

Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding

31 March 2020

1 reference

Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: preliminary results

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRD937

1 reference

5 August 2017

1 reference

PubMed ID

12415247